DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE:ABBV) on 10/29/2021 declared a dividend of $1.4100 per share

AbbVie Inc (NYSE:ABBV) on 10/29/2021 declared a dividend of $ 1.4100 per share payable on February 15, 2022 to shareholders of record as of January 14, 2022. Dividend amount recorded is an increase of $ 0.11 from last dividend Paid.

AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 5.1427006721% and has increased its dividends for 7 successive years.

AbbVie Inc's market cap is $ 193,806,191,920 and has a PE ratio of 30.05. The stock price closed yesterday at $ 109.67 and has a 52 week low/high of $ 79.11 and $ 121.53.

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.

For more information on AbbVie Inc click here.